A

Ambagon Therapeutics

47 employees

AmbAgon Therapeutics is a developer of cancer molecule therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Product Research
Medical

Date founded

2020

Funding rounds raised

Total raised

$85M

from 5 investors over 5 rounds

A

Ambagon Therapeutics raised $85M on January 6, 2022

Investors: Nextech Invest, RA Capital Management, L.P., Mission BioCapital, Inkef and Surveyor Capital

FAQ